Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert J Czaja

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
European Journal of Clinical Investigation|February 1, 2018
Epigenetic changes and their implications in autoimmune hepatitisAlbert J Czaja
Current Opinion in Gastroenterology|October 13, 2006
Autoimmune liver diseaseAlbert J Czaja
Alimentary Pharmacology & Therapeutics|May 5, 2020
Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitisAlbert J Czaja
Alimentary Pharmacology & Therapeutics|May 11, 2019
Letter: high ferritin to haemoglobin ratio is related to early mortality in patients with alcoholic hepatitis - author's replyAlbert J Czaja
Expert Review of Clinical Immunology|May 5, 2022
Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitisAlbert J Czaja
Digestive Diseases and Sciences|February 11, 2022
Advancing Biologic Therapy for Refractory Autoimmune HepatitisAlbert J Czaja
Digestive Diseases and Sciences|April 30, 2010
Late relapse of type 1 autoimmune hepatitis after corticosteroid withdrawalAlbert J Czaja
Digestive Diseases and Sciences|May 14, 2010
Autoantibodies as prognostic markers in autoimmune liver diseaseAlbert J Czaja
Hepatology (Baltimore, Md.)|October 17, 2008
Performance parameters of the diagnostic scoring systems for autoimmune hepatitisAlbert J Czaja
Current Opinion in Gastroenterology|April 24, 2009
Autoimmune liver diseaseAlbert J Czaja
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
European Journal of Clinical Investigation|February 1, 2018
Epigenetic changes and their implications in autoimmune hepatitisAlbert J Czaja
Current Opinion in Gastroenterology|October 13, 2006
Autoimmune liver diseaseAlbert J Czaja
Alimentary Pharmacology & Therapeutics|May 5, 2020
Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitisAlbert J Czaja
Alimentary Pharmacology & Therapeutics|May 11, 2019
Letter: high ferritin to haemoglobin ratio is related to early mortality in patients with alcoholic hepatitis - author's replyAlbert J Czaja
Expert Review of Clinical Immunology|May 5, 2022
Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitisAlbert J Czaja
Digestive Diseases and Sciences|February 11, 2022
Advancing Biologic Therapy for Refractory Autoimmune HepatitisAlbert J Czaja
Digestive Diseases and Sciences|April 30, 2010
Late relapse of type 1 autoimmune hepatitis after corticosteroid withdrawalAlbert J Czaja
Digestive Diseases and Sciences|May 14, 2010
Autoantibodies as prognostic markers in autoimmune liver diseaseAlbert J Czaja
Hepatology (Baltimore, Md.)|October 17, 2008
Performance parameters of the diagnostic scoring systems for autoimmune hepatitisAlbert J Czaja
Current Opinion in Gastroenterology|April 24, 2009
Autoimmune liver diseaseAlbert J Czaja
Pageof 16